MedPath

PerkinElmer Wallac Oy

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)

Conditions
Trisomy 18
Trisomy 13
Trisomy 21
First Posted Date
2018-06-18
Last Posted Date
2018-08-29
Lead Sponsor
PerkinElmer, Wallac Oy
Target Recruit Count
1200
Registration Number
NCT03559374
Locations
🇮🇹

Centro Screening neonatale e prenatale del Piemonte e Valle d'Aosta AOU Città della Salute e della Scienza di Torino, Turin, Italy

Median Study for Biochemical Serum Markers in First Trimester of Pregnancy

Completed
Conditions
Pregnancy
First Posted Date
2013-07-03
Last Posted Date
2015-09-28
Lead Sponsor
PerkinElmer, Wallac Oy
Target Recruit Count
200
Registration Number
NCT01891370
Locations
🇲🇾

Hospital Tuanku Jaafar, Seremban, Malaysia

🇵🇭

MCU-FDT Medical Foundation, Caloocan City, Philippines

🇹🇭

Khon Kaen University, Khon Kaen, Thailand

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.